Magazine Article | February 1, 2022

Early On, Biotechs Need To Be Thinking Commercialization

Source: Life Science Leader

By Holly May

It is easy to lose sight of the importance of a commercial mindset early in the life of a biotech. Many companies fail to see or understand its value proposition or its critical role in the creation of clinical development plans. Unfortunately, because the access and reimbursement stakes are so high in this market segment, operating without a commercial lens and throwing a product over the fence to the commercial team a couple of years prior to launch with the expectation that they can take it to market and sell it are not luxuries many biotechs can afford.

access the Magazine Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Life Science Leader